Skip to content

Psychedelic-assisted therapy: all studies

Page 233 of 294: studies 2,321 to 2,330 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Healing at death’s door: one patient’s mystical experience with psilocybin

International Journal of Whole Person Care January 6, 2023 Houman Farzin 1 citation

eath is of the most certain and undeniable truths in an existence shrouded by mysteries and unknowns, yet many don't have the opportunity for a meaningful reflection on this matter until the very end of their life.Existential suffering often awaits at death's door while effective solutions remain limited.The reality is that saving lives has been a key pillar of our medical ethos and so the...

The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review

Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal January 5, 2023 Kaden Venugopal, Nefissa Bedri 5 citations

Introduction: Psilocybin (the active compound found in “magic mushrooms”) has been an area of recent focus in the academic and psychiatric community on account of its potential in treating a spectrum of substance use and concurrent disorders (SUCDs). This paper posits a literature review of the current research pertaining to psilocybin in treating alcohol use disorder (AUD) through a form of...

Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst

January 4, 2023 Sidsel Dahl Andersen preprint

Self or ego dissolution (SED) is a recurring, yet vaguely defined phenomenon often associated with positive therapeutic outcomes within clinical research on classic psychedelic substances. The aim of this thesis is to achieve a deeper understanding and improve terminological clarity of SED in a psychedelic context, here defined as research settings in which moderate to high doses of psilocybin...

DOI: 10.31234/osf.io/f26ce (opens in new tab) Full text (opens in new tab) Psychoanalytic theory Subject documents Context archaeology Feeling +3

Steroids, plastic, and psychedelics: the interlinking of epistemic coalition infighting and domestic perception in creating third-order policy change

2023 Giuliano Espino

Epistemic coalitions are international nonstate actors comprised of technical experts, political advocates, and private sector representatives. Discussion of epistemic coalitions has been until recently subsumed within the larger discussion of epistemic communities, which are organizations solely comprised of technical experts. This dissertation seeks to build upon a recent scholarly trend of...

Invoking the Numinous: Ritual, Medicine, and Magic in Psychedelic Psychotherapy

Integral Psychedelic Therapy the Non Ordinary Art of Psychospiritual Healing 2023

In this chapter, Shanna Butler and Camara Rajabari offer recommendations for cultivating client-centered, culturally sensitive ritual in psychedelic-assisted therapy. The authors thoughtfully describe the impact of colonization, white supremacy, and cultural appropriation on psychedelic-assisted therapy. Speaking from within their own experiences of ritual as a practice of social justice, they...

Italian psychedelic therapies of the past century: An historical overview

Drug Science, Policy and Law 2023 Adriana D’arienzo, Giorgio Samorini

In recent years, the historical record of psychedelic therapy in Europe and the Americas has undergone considerable revision. In this article, we contribute to this re-interpretation by sharing documentation relating to psychedelic therapy carried out in Italy during the period 1927–1966. Our library research has uncovered one hundred publications, documenting at least 60 clinical studies in...

Psychedelic Drug Therapy for Mental Disorders?

Open Journal of Medical Psychology 2023 John R. Rossiter 1 citation

Objective: Psychedelic drug therapy is banned in all countries of the world except Australia, where the government regulatory watchdog, the Therapeutic Goods Administration, is planning to allow approved psychiatrists, as of July 1, 2023, to prescribe psilocybin to treat depression and MDMA to treat post-traumatic stress disorder, a move precipitated by the U.S. Food and Drug Administration’s...

Pattern breaking: a complex systems approach to psychedelic medicine

Neuroscience of Consciousness 2023 Inês Hipólito, Jonas Mago, Fernando E. Rosas et al. 60 citations

Abstract Recent research has demonstrated the potential of psychedelic therapy for mental health care. However, the psychological experience underlying its therapeutic effects remains poorly understood. This paper proposes a framework that suggests psychedelics act as destabilizers, both psychologically and neurophysiologically. Drawing on the ‘entropic brain’ hypothesis and the ‘RElaxed...

DOI: 10.1093/nc/niad017 (opens in new tab) Full text (opens in new tab) Cognitive science Artificial intelligence Cognitive psychology

Self-Care Practices with Psychedelics - A Qualitative Study of Users' Perspectives.

Journal of Psychoactive Drugs 2023 Carla Mendes Soares, Ângela Leite, Marta Pinto 10 citations

This article explores the psychedelic experience from the users' point of view and through the lens of self-care, a concept within the domain of health and well-being. In a time of renewed interest in psychedelic-assisted psychotherapy, we aim to contribute to a better understanding of these substances by exploring their role in different settings. A phenomenological approach was used in this...

DOI: 10.1080/02791072.2022.2071134 (opens in new tab) Full text (opens in new tab) Psychedelics Qualitative research Hallucinogens Self-care

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.

JAMA Psychiatry 2023 Brian D Kiluk, Bethea A Kleykamp, Sandra D Comer et al. 22 citations

Novel treatments for opioid use disorder (OUD) are needed to address both the ongoing opioid epidemic and long-standing barriers to existing OUD treatments that target the endogenous μ-opioid receptor (MOR) system. The goal of this review is to highlight unique clinical trial design considerations for the study of emerging treatments for OUD that address targets beyond the MOR system. In...